Considerations for CAR T Use Across Large B-Cell Lymphoma Variants
Jose Sandoval Sus, MD, discussed the “revolution” that CAR T-cell therapies have facilitated for patients with large B-cell lymphomas.
Previous Post
In internal FDA town hall, employees raise concerns about staffing, impromptu expert meetings
Next Post
STAT+: Trump administration launches investigation into Harvard’s federally funded research patents
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago